ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Weight loss is a highly effective treatment for non‐alcoholic fatty liver disease, but SH‐BC‐893 may also improve fatty liver disease by reducing mitochondrial fission in hepatocytes (Fig 3B–D, Galloway et al, 2014) and increasing adiponectin levels (Fig 5A and J, Xu et al, 2003).